Northeast Georgia Health System recently expanded it’s medical staff of professions looking to treat cancers.
Six new surgeons, radiation oncologists and specialists have joined the health system’s cancer program, improving patients’ to access to advanced cancer care. NGHS’ Cancer Services team offers specialties like surgical procedures, radiation, gynecologic oncology as well as hematology and medical oncology.
“When you or a loved one learns you have cancer, the last thing anyone wants to think about is driving long distances to get treatment and finding a place to stay,” April Radford, executive director of Cancer Services at NGHS, said. “Welcoming these outstanding providers to our team enhances our ability to provide advanced cancer care to those near and far – from the suburbs of Atlanta to the shores of Lake Lanier, to the Blue Ridge mountains and beyond.”
Dr. Maurice Asouzu and Dr. Mary Read, both general surgeons with Longstreet Clinic, joined the NGHS Cancer Services team last summer, according to the health system. Dr. Read specializes in breast care and surgery, including breast cancer care, while Dr. Asouzu focuses on general surgery.
Dr. James Taylor and Dr. Allison Hazy, both of Northeast Georgia Physicians Group (NGPG) Radiation Oncology, joined the team in 2024 and now lend their own expertise to the cancer care program.
Two physician assistants, Micaela Campagna and Katelyn Malbrecht, recently joined Dr. Chelsea Chandler at NGPG Gynecologic Oncology as the latest additions to the team.
“By bringing in these highly specialized providers, we are enhancing cancer care in our region,” said Andrew Johnson, MD, medical director of Cancer Services at NGHS and medical oncologist with Longstreet Clinic. “Our goal is to provide every patient with personalized, innovative options close to home, ensuring they receive the highest level of care in a supportive environment.”
This expansion comes as NGMC continues to seek advancements in cancer care. The health system recently announced a move that made it the first and only hospital in Georgia – and one of the few in the United States – to offer histotripsy, a groundbreaking, non-invasive treatment for liver tumors. This technology uses focused ultrasound waves to eliminate cancerous tissue.
NGMC also previously became the first to offer the BOOMBOX clinical trial, which is focused on patients with liver tumors. The trial uses histotripsy to target and treat liver tumors.
“We are honored to be the first in the world to offer the BOOMBOX clinical trial to patients undergoing histotripsy,” Dr. Charles Nash, medical director of Research at NGMC, said. “This is a tremendous milestone in the advancement in cancer treatment. Our participation in this groundbreaking research underscores our commitment to leading the way in cancer care and ensuring our patients have access to the most progressive treatment available.”
